Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 53 citing Nissenson: Recombinant human erythropoietin and renal anemia: molecular biology, clinical.... (0.13 sec) 

Anemia and renal insufficiency are independent risk factors for death among patients with …

- asnjournals.org
WM McClellan, WD Flanders, RD Langston, C … - Journal of the American Society of Nephrology, 2002 - Am Soc Nephrol
ABSTRACT. The purpose of this retrospective cohort study was to examine the
associations among chronic kidney disease, anemia, and risk of death among
patients with heart failure. Retrospective cohort study. Patients with a ...
Cited by 292 - Related articles - BL Direct - All 6 versions

Effect of serum parathyroid hormone and bone marrow fibrosis on the response to …


DS Rao, M Shih, R Mohini - The New England journal of medicine, 1993 - nejm.highwire.org
Background and Methods Anemia is common in patients with chronic renal
insufficiency and secondary hyperparathyroidism. Erythropoietin therapy is
effective, but the dose required varies greatly. One possible determinant ...
Cited by 219 - Related articles - BL Direct - All 5 versions

-Carnitine effects on anemia in hemodialyzed patients treated with erythropoietin* 1


WD Labonia - American Journal of Kidney Diseases, 1995 - Elsevier
To demonstrate whether -carnitine treatment could further improve the anemia in
dialyzed patients under recombinant human erythropoietin (r-HuEPO) therapy,
leading to a reduction in r-HuEPO requirements, -carnitine (1 g ...
Cited by 115 - Related articles - BL Direct - All 5 versions

Association of high serum creatinine and anemia increases the risk of coronary events: …

- asnjournals.org
CT Jurkovitz, JL Abramson, LV Vaccarino, … - Journal of the American Society of Nephrology, 2003 - Am Soc Nephrol
Cardiovascular disease (CVD) mortality rates in ESRD are approximately 15 times
higher than in the general population (1). Many studies examining the
association between ESRD and cardiovascular mortality (2,3) have found that ...
Cited by 110 - Related articles - BL Direct - All 6 versions

Beneficial effect of renal transplantation on cognitive brain function


L Kramer, C Madl, F Stockenhuber, W … - Kidney international, 1996 - nature.com
Beneficial effect of renal transplantation on cognitive brain function.
Cognitive brain dysfunction is a common complication of end-stage renal disease.
To investigate the cerebral effect of renal transplantation, we studied ...
Cited by 59 - Related articles - BL Direct - All 3 versions

Effect of recombinant erythropoietin on hospital admissions, readmissions, length of stay, and …

- asnjournals.org [PDF] 
NR Powe, RI Griffiths, AJ Watson, GF … - Journal of the American Society of Nephrology, 1994 - Am Soc Nephrol
Page 1. Journal of the American Society of Nephrology 1455 Effect of Recombinant
Erythropoietin on Hospital Admissions, Readmissions ...
Cited by 37 - Related articles - BL Direct - All 4 versions

Recombinant human erythropoietin for the treatment of the anaemia associated with …


J LOIS, AE AYASH, GD MYLA HUNT, W … - British Journal ofHuematoZogy, 1994 - interscience.wiley.com
Summary. Patients with solid tumours undergoing highdose chemotherapy with
autologous bone marrow transplantation use an average of 10 units of packed red
blood cells (PRBC) while awaiting haemopoietic reconstitution. They are ...
Cited by 33 - Related articles - BL Direct - All 3 versions

Pharmacokinetics of recombinant human erythropoietin applied subcutaneously to children …


A Braun, R Ding, C Seidel, T Fies, A Kurtz, K … - Pediatric Nephrology, 1993 - Springer
Abstract. The single-dose pharmacokinetics of recombi- nant human erythropoietin
(rHuEPO) given SC was inves- tigated in 20 patients aged 7-20 years at different
stages of chronic renal failure. In a pilot study we confirmed the lower ...
Cited by 25 - Related articles - BL Direct - All 3 versions

Cerebral venous thrombosis associated with epoetin alfa therapy


PF Finelli, MD Carley - Archives of Neurology, 2000 - Am Med Assoc
Case Description A 37-year-old patient who was receiving peritoneal dialysis and
epoetin alfa (Epogen) therapy presented with a several-day history of worsening
headache, and a neuroimaging scan demonstrated thrombosis of the sagittal ...
Cited by 23 - Related articles - BL Direct - All 5 versions

Early dosing practices and effectiveness of recombinant human erythropoietin


NR Powe, RI Griffiths, JW Greer, AJ Watson, … - Kidney international, 1993 - nature.com
Early dosing practices and effectiveness of recombinant human erythropoietin. In
a national longitudinal-cohort study of 59,462 end-stage renal disease (ESRD)
patients, we examined dosing and effectiveness of erythropoietin (EPO) ...
Cited by 21 - Related articles - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google